JPS6234392B2 - - Google Patents

Info

Publication number
JPS6234392B2
JPS6234392B2 JP54170926A JP17092679A JPS6234392B2 JP S6234392 B2 JPS6234392 B2 JP S6234392B2 JP 54170926 A JP54170926 A JP 54170926A JP 17092679 A JP17092679 A JP 17092679A JP S6234392 B2 JPS6234392 B2 JP S6234392B2
Authority
JP
Japan
Prior art keywords
brevibacterium
medium
ferm
acoh
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54170926A
Other languages
Japanese (ja)
Other versions
JPS5692784A (en
Inventor
Osamu Tosaka
Eiji Ono
Masaru Ishihara
Hajime Morioka
Yutaka Murakami
Shigeo Ikeda
Yasutsugu Yamada
Hiroi Yoshii
Koichi Takinami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP17092679A priority Critical patent/JPS5692784A/en
Publication of JPS5692784A publication Critical patent/JPS5692784A/en
Publication of JPS6234392B2 publication Critical patent/JPS6234392B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

この発明はブレビバクテリウム
(Brevibacterium)属の新規変異株に関する。 本発明者らは、ブレビバクテリウム属に属する
微生物より、酢酸要求性を有する変異株を誘導、
分離することに成功した。この新規変異株は、炭
素源に対するアミノ酸の生成効率が高く、L―ア
ルギニン,L―グルタミン,L―グルタミン酸,
L―ヒスチジン,L―イソロイシン,L―ロイシ
ン,L―メチオニン,L―オルニチン,L―フエ
ニルアラニン,L―スレオニン,L―バリン,L
―トリプトフアン等のアミノ酸生産菌として有益
である。 即ち、この発明は、ブレビバクテリウム属に属
し酢酸要求性を有する変異株である。 本発明の変異株の代表例としては以下のものが
ある。 ブレビバクテリウム・フラバム AJ11277
FERM―P4551(AEC〓,AcOH-;L―リジン
生産菌) ブレビバクテリウム・フラバム AJ11278
FERM―P4552(AEC〓,Hse-,AcOH-;L―
リジン生産菌) ブレビバクテリウム・ラクトフエルメンタム
AJ11280 FERM―P4554(AEC〓,CCL〓,
Ala-,AcOH-;L―リジン生産菌) ブレビバクテリウム・ラクトフエルメンタム
AJ11515 FERM―P5335(AcOH-) ブレビバクテリウム・ラクトフエルメンタム
AJ11516 FERM―P5336(AcOH-,イソクエン
酸リアーゼ低下;L―グルタミン酸生産菌) ブレビバクテリウム・フラバム AJ11517
FERM―P5337(AcOH-,L―グルタミン酸生産
菌) AEC〓:S―(2―アミノエチル)―システ
イン耐性。 Hse-:L―ホモセリン要求性。 CCL〓:α―クロロカプロラクタム耐性。 Ala-:L―アラニン要求性。 AcOH-:酢酸要求性。 上記例示の変異株の親株は、ブレビバクテリウ
ム・ラクトフエルメンタムATCC13869及びブレ
ビバクテリウム・フラバムATCC14067である。
その他にブレビバクテリウム・イムマリオフイル
ムATCC14068,ブレビバクテリウム・サツカロ
リテイクムATCC14066,ブレビバクテリウム・
デイバリカタムATCC14020,ブレビバクテリウ
ム・ロゼウムATCC13825等のブレビバクテリウ
ム属の特にL―グルタミン酸生産菌として知られ
ている一群の微生物が親株として好適である。更
に上記例示の野性株のほかに、アミノ酸要求性,
薬剤耐性等が付与された変異株を親株として使用
してもよい。 変異誘導方法は、紫外線照射,X線照射,放射
線照射,変異誘起剤処理等の通常の方法のいずれ
もが用いられる。 このような変異株を培養する培地は、炭素源、
窒素源、無機イオン及び更に必要ならば有機微量
栄養素を含有する通常の培地である。炭素源とし
ては炭水化物(グルコース,フラクトース,シユ
ークロース等及びこれらを含有する糖蜜,スター
チ加水分解物,果汁,セルロース分解物等)、ア
ルコール(エタノール,グリセリン等)、有機酸
(酢酸,プロピオン酸,グルコン酸,高級脂肪酸
等)等が使用できる。窒素源としては尿素、アン
モニウム塩、アンモニア水、アンモニアガス、そ
の他通常の窒素源が用いられる。無機イオンとし
てはリン酸イオン、マグネシウムイオン、カリウ
ムイオン等適宜必要に応じて培地に添加される。 培養は好気的条件下で行うのが良く、温度24〜
39℃、PH5.0〜9.0で行えば最も好ましい結果が得
られる。 PHの調整には無機あるいは有機の酸あるいはア
ルカリ、更には尿素、炭酸カルシウム、アンモニ
アガスなどを使用することができる。 実施例 1 ブレビバクテリウム・フラバムATCC21475
(AEL〓)をN―メチル―N′―ニトロ―N―ニト
ロソグアニジンにて処理(250μg/ml,30℃で
30分)した後、以下に示す最少培地に、酢酸0.2
%添加した培地で生育し、かつ添加しない培地で
生育できないコロニーを、レプリカ法で採取し
た。 最少培地組成 グルコース 2g/dl 尿素 0.25g/dl 硫酸アンモニウム 1g/dl KH2PO4 0.1g/dl MgSO4・7H2O 0.04g/dl FeSO4・7H2O 1mg/dl MnSO4・4H2O 1mg/dl ビオチン 50μg/ サイアミン塩酸塩 100μg/ NaCl 5mg/dl L―アラニン 50mg/dl ニコチン酸アミド 0.5mg/dl L―ホモセリン 50mg/dl (PH) (7.2) このようにして得られた生育に酢酸を必要と
し、かつホモセリン要求性及び/又は、リジンア
ナログに耐性を有する菌の内、L―リジン生産能
の優れた変異株として、AJ11277(FERM―
P4551)(AEC〓・AcOH-)、及びAJ11278
(FERM―P4552)(AEC〓・Hse-・AcOH-)を採
取した。 更に同様の方法によりブレビバクテリウム・ラ
クトフアーメンタムAJ11082(FERM―P3840)
(AEC〓,CCL(α―クロロカプロラクタム))
〓,Ala-)を親株として酢酸要求性を有する変異
株AJ11280(FERM―P4554)(AEC〓,
CCL〓,Ala-,AcOH-)を採取した。 下記の組成の培地を20ml宛、500ml容振とうフ
ラスコに分注し、110℃にて5分間蒸気殺菌し
た。 培地組成 グルコース 10g/dl 硫酸アンモニウム 4.5g/dl KH2PO4 0.1g/dl MgSO4・7H2O 0.04g/dl FeSO4・7H2O 1.0mg/dl MnSO4・4H2O 1.0mg/dl ビオチン 500μg/ サイアミン塩酸塩 200μg/ 大豆タンパク塩酸加水分解液濃縮物
1.5mg/dl (総窒素7%) 炭酸カルシウム(別殺菌添加) 5.0g/dl (PH7.0) 上記の如く調整したフラスコ中の培地に、あら
かじめグルコーズ・ブイヨンスラント上で生育せ
しめた第1表に示す菌株を1白金耳づつ接種し、
それらを31℃にて72時間振とう培養した。72時間
培養後の培地中のL―リジン生成量を、酸性―銅
ニンヒドリン反応を用いる比色法によつて行た。
結果を第1表に示す。
The present invention relates to novel mutant strains of the genus Brevibacterium. The present inventors derived a mutant strain with acetic acid auxotrophy from a microorganism belonging to the genus Brevibacterium.
succeeded in separating. This new mutant strain has high efficiency in producing amino acids from carbon sources, including L-arginine, L-glutamine, L-glutamic acid,
L-histidine, L-isoleucine, L-leucine, L-methionine, L-ornithine, L-phenylalanine, L-threonine, L-valine, L
- Useful as a bacterium that produces amino acids such as tryptophan. That is, the present invention is a mutant strain that belongs to the genus Brevibacterium and has acetic acid auxotrophy. Representative examples of the mutant strains of the present invention include the following. Brevibacterium flavum AJ11277
FERM-P4551 (AEC〓, AcOH - ; L-lysine producing bacterium) Brevibacterium flavum AJ11278
FERM―P4552 (AEC〓, Hse - , AcOH - ; L―
Lysine producing bacteria) Brevibacterium lactofermentum
AJ11280 FERM―P4554 (AEC〓, CCL〓,
Ala - , AcOH - ; L-lysine producing bacteria) Brevibacterium lactofermentum
AJ11515 FERM―P5335 (AcOH - ) Brevibacterium lactofermentum
AJ11516 FERM-P5336 (AcOH - , isocitrate lyase reduction; L-glutamic acid producing bacteria) Brevibacterium flavum AJ11517
FERM-P5337 (AcOH - , L-glutamic acid producing bacteria) AEC〓: S-(2-aminoethyl)-cysteine resistant. Hse - : L-homoserine requirement. CCL: α-chlorocaprolactam resistance. Ala - : L-alanine requirement. AcOH - : Acetic acid requirement. The parent strains of the above-exemplified mutants are Brevibacterium lactofermentum ATCC13869 and Brevibacterium flavum ATCC14067.
In addition, Brevibacterium immariophyllum ATCC14068, Brevibacterium satucaroliticum ATCC14066, Brevibacterium
A group of microorganisms of the genus Brevibacterium, particularly known as L-glutamic acid-producing bacteria, such as Brevibacterium devaricata ATCC 14020 and Brevibacterium roseum ATCC 13825, are suitable as parent strains. Furthermore, in addition to the wild strains exemplified above, amino acid-requiring,
A mutant strain imparted with drug resistance or the like may be used as a parent strain. Any of the usual methods such as ultraviolet irradiation, X-ray irradiation, radiation irradiation, mutagenic agent treatment, etc. can be used as the mutation induction method. The medium for culturing such mutant strains contains a carbon source,
It is a conventional medium containing a nitrogen source, inorganic ions and, if necessary, organic micronutrients. Carbon sources include carbohydrates (glucose, fructose, sucrose, etc. and molasses containing these, starch hydrolysates, fruit juices, cellulose decomposition products, etc.), alcohols (ethanol, glycerin, etc.), and organic acids (acetic acid, propionic acid, gluconic acid, etc.). , higher fatty acids, etc.) can be used. As the nitrogen source, urea, ammonium salt, aqueous ammonia, ammonia gas, and other common nitrogen sources are used. As inorganic ions, phosphate ions, magnesium ions, potassium ions, etc. are added to the medium as appropriate and necessary. Cultivation is best carried out under aerobic conditions, with temperatures between 24 and
The most favorable results will be obtained if carried out at 39°C and pH 5.0 to 9.0. To adjust the pH, inorganic or organic acids or alkalis, as well as urea, calcium carbonate, ammonia gas, etc. can be used. Example 1 Brevibacterium flavum ATCC21475
(AEL〓) was treated with N-methyl-N'-nitro-N-nitrosoguanidine (250μg/ml, at 30℃).
30 min), then add 0.2 acetic acid to the minimal medium shown below.
Colonies that grew in the medium with % addition and could not grow in the medium without addition were collected by the replica method. Minimum medium composition Glucose 2g/dl Urea 0.25g/dl Ammonium sulfate 1g/dl KH 2 PO 4 0.1g/dl MgSO 4・7H 2 O 0.04g/dl FeSO 4・7H 2 O 1mg/dl MnSO 4・4H 2 O 1mg /dl Biotin 50μg/ Thiamine hydrochloride 100μg/ NaCl 5mg/dl L-alanine 50mg/dl Nicotinamide 0.5mg/dl L-homoserine 50mg/dl (PH) (7.2) Add acetic acid to the growth thus obtained. AJ11277 (FERM-
P4551) (AEC〓・AcOH - ), and AJ11278
(FERM-P4552) (AEC〓・Hse ・AcOH ) was collected. Furthermore, using the same method, Brevibacterium lactofamentum AJ11082 (FERM-P3840)
(AEC〓, CCL (α-chlorocaprolactam))
Mutant strain AJ11280 (FERM-P4554) (AEC〓,
CCL〓, Ala - , AcOH - ) were collected. 20 ml of a medium having the composition shown below was dispensed into a 500 ml shaking flask and steam sterilized at 110°C for 5 minutes. Medium composition Glucose 10g/dl Ammonium sulfate 4.5g/dl KH 2 PO 4 0.1g/dl MgSO 4・7H 2 O 0.04g/dl FeSO 4・7H 2 O 1.0mg/dl MnSO 4・4H 2 O 1.0mg/dl Biotin 500μg/ Thiamine hydrochloride 200μg/ Soy protein hydrolysis solution concentrate
1.5 mg/dl (total nitrogen 7%) Calcium carbonate (separate sterilization added) 5.0 g/dl (PH7.0) Table 1 was prepared by growing on glucose bouillon slant in advance in the medium in the flask prepared as above. Inoculate one platinum loopful of the bacterial strain shown in
They were cultured with shaking at 31°C for 72 hours. The amount of L-lysine produced in the medium after 72 hours of culture was determined by a colorimetric method using an acidic-copper ninhydrin reaction.
The results are shown in Table 1.

【表】 AJ11277株の培養終了液を集め遠心分離によつ
て、菌体及びカルシウム塩を除いた上清液1
を、強酸性イオン交換樹脂(「アンバーライト」
IR―120OH型)に通過させ、L―リジンを吸着
させた。ついで、3%アンモニア水で吸着したL
―リジンを溶出し、溶出液を減圧濃縮した。濃縮
液に塩酸を添加したのち冷却さ、L―リジンをL
―リジン塩酸塩第2水加物として析出させ、結晶
22.5gを得た。 実施例 2 ブレビバクテリウム・ラクトフエルメンタム
ATCC13869及びブレビバクテリウム・フラバム
ATCC14067を、それぞれ200μg/mlのN―メチ
ル―N′―ニトロ―N―ニトロソグアニジンで0
℃で20分間処理し、酢酸要求性変異株AJ11515,
AJ11516及びAJ11517を得た。 これらの菌株の酢酸添加濃度に対する生育度を
第2表に示す。各菌株の生育度は、次のようにし
て検出した。 グルコース0.5g/dl,尿素0.15g/dl,硫安
0.15g/dl,KH2PO40.3g/dl,K2HPO40.1g/
dl,MgSO4・7H2O0.01g/dl,CaCl2・2H2O0.1
mg/dl,サイアミン塩酸塩10μg/dl,ビオチン
3μg/dl,Na2B4O7・10H2O0.44mg/dl,
FeCl2・6H2O4.85mg/dl,CuSO4・5H2O1.95
mg/dl,(NH46Mo7O24・4H2O0.185mg/dl,
ZnSO4・7H2O44mg/dl,MnCl2・4H2O0.36mg/
dl及び表に示す量の酢酸を含みPH7.0に
[Table] Supernatant liquid 1 after collecting the cultured liquid of AJ11277 strain and removing bacterial cells and calcium salts by centrifugation.
, a strongly acidic ion exchange resin (“Amberlite”)
IR-120OH type) to adsorb L-lysine. Then, L adsorbed with 3% ammonia water
-Lysine was eluted, and the eluate was concentrated under reduced pressure. After adding hydrochloric acid to the concentrate, it was cooled and L-lysine was added to L-lysine.
-Precipitated as lysine hydrochloride secondary hydrate, crystallized
22.5g was obtained. Example 2 Brevibacterium lactofermentum
ATCC13869 and Brevibacterium flavum
ATCC14067 was treated with 200 μg/ml of N-methyl-N′-nitro-N-nitrosoguanidine.
acetic acid auxotrophic mutant AJ11515, treated for 20 min at °C.
AJ11516 and AJ11517 were obtained. Table 2 shows the growth rates of these strains relative to the concentration of acetic acid added. The growth rate of each strain was detected as follows. Glucose 0.5g/dl, Urea 0.15g/dl, Ammonium sulfate
0.15g/dl, KH 2 PO 4 0.3g/dl, K 2 HPO 4 0.1g/
dl, MgSO 4・7H 2 O0.01g/dl, CaCl 2・2H 2 O0.1
mg/dl, thiamine hydrochloride 10 μg/dl, biotin 3 μg/dl, Na 2 B 4 O 7・10H 2 O 0.44 mg/dl,
FeCl 2・6H 2 O4.85mg/dl, CuSO 4・5H 2 O1.95
mg/dl, (NH 4 ) 6 Mo 7 O 24・4H 2 O0.185 mg/dl,
ZnSO 4・7H 2 O44mg/dl, MnCl 2・4H 2 O0.36mg/
Contains dl and the amount of acetic acid shown in the table and has a pH of 7.0.

【表】【table】

【表】 調整した培地に、天然培地(ペプトン1g/dl,
酵母エキス1g/dl,NaCl0.5g/dl,PH7.0)ス
ラントで24時間培養した菌を無菌水で懸濁して接
種し、24時間培養して生育値を濁度で測定した。 又、上記例示のイソクエン酸リアーゼ(以下
ICLと略記する。)低下株のICL活性を第3表に示
す。 ICL活性は次のようにして検定した。
[Table] Natural medium (peptone 1g/dl,
(Yeast extract 1g/dl, NaCl 0.5g/dl, PH7.0) Bacteria cultured on a slant for 24 hours were suspended in sterile water and inoculated, cultured for 24 hours, and the growth value was measured by turbidity. In addition, the above-mentioned isocitrate lyase (hereinafter referred to as
Abbreviated as ICL. ) The ICL activity of the reduced strains is shown in Table 3. ICL activity was assayed as follows.

【表】 グルコーズ2.5g/dl,酢酸アンモニウム0.8
g/dl,KH2PO40.1g/dl,MgSO4・7H2O0.1
g/dl,FeSO4・7H2O1mg/dl,MnSO4・4H2O1
mg/dl,尿素0.4g/dl,ビオチン0.3μg/dl,
サイアミン塩酸塩20μg/dl,及び大豆分解濃縮
液(T―Nとして)48mg/dl(PH7.0)を含有す
る培地を調整し、その20mlずつを500ml容振盪フ
ラスコに入れ、115℃で10分間加熱殺菌した。こ
の培地に試験菌株を接種し、往復振盪培養機によ
り31.5℃で、対数増殖初期(10〜16時間)まで培
養した。培養液より菌体を分離し、洗浄後超音波
破砕し、セフアデツクスG―10で処理したものを
酵素標品として用いた。 酵素活性の測定は、椎尾らの方法に準じて行つ
た。(ジヤーナル・オブ・バイオケミストリー49
巻,262頁,1961年) グルコーズ2.3g/dl,酢酸アンモニウム1
g/dl,酢酸ナトリウム1g/dl,KH2PO40.1
g/dl,MgSO4・7H2O0.1g/dl,サイアミン・
塩酸塩20μg/dl,尿素0.6g/dl,FeSO4
7H2O1mg/dl,MnSO4・4H2O1mg/dl,大豆分解
濃縮液(T―Nとして)36mg/dl及びビオチン2
μg/(PH7.0)を含有する培地を調製し、そ
の20mlずつを500ml容振盪フラスコに入れ115℃で
10分加熱殺菌した。この培地にそれぞれ下記の表
の菌を接種し往復振盪培養液により31.5℃で培養
を行つた。 なお、培養中は培養液をPH6.5〜8.0に保つた
め、45g/dl尿素又は2NH2SO4を用いて調節し
た。36時間で培養を終了し、培養液中に蓄積した
L―グルタミン酸の対基質収率を求めた。 その結果を、次の第4表に示す。
[Table] Glucose 2.5g/dl, ammonium acetate 0.8
g/dl, KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O0.1
g/dl, FeSO 4・7H 2 O1mg/dl, MnSO 4・4H 2 O1
mg/dl, urea 0.4g/dl, biotin 0.3μg/dl,
Prepare a medium containing 20 μg/dl of thiamine hydrochloride and 48 mg/dl (PH7.0) of soybean decomposition concentrate (as TN), put 20 ml of each into a 500 ml shaking flask, and incubate at 115°C for 10 minutes. Heat sterilized. The test strain was inoculated into this medium and cultured at 31.5°C in a reciprocating shaking incubator until the early stage of logarithmic growth (10 to 16 hours). Bacterial cells were isolated from the culture solution, washed, disrupted by ultrasonication, and treated with Sephadex G-10, and used as an enzyme preparation. Enzyme activity was measured according to the method of Shiio et al. (Journal of Biochemistry 49
Vol. 262, 1961) Glucose 2.3g/dl, Ammonium acetate 1
g/dl, sodium acetate 1g/dl, KH 2 PO 4 0.1
g/dl, MgSO 4・7H 2 O0.1g/dl, Thiamine・
Hydrochloride 20μg/dl, urea 0.6g/dl, FeSO 4 .
7H2O1mg /dl, MnSO44H2O1mg /dl, soybean decomposition concentrate (as T-N) 36mg/dl and biotin 2
Prepare a medium containing μg/(PH7.0) and place 20 ml of it into a 500 ml shake flask at 115°C.
Sterilized by heating for 10 minutes. Each of the bacteria shown in the table below was inoculated into this medium and cultured at 31.5°C using a reciprocating shaking culture solution. During cultivation, the pH of the culture solution was adjusted to 6.5 to 8.0 using 45 g/dl urea or 2NH 2 SO 4 . The culture was terminated after 36 hours, and the substrate yield of L-glutamic acid accumulated in the culture solution was determined. The results are shown in Table 4 below.

【表】【table】

Claims (1)

【特許請求の範囲】[Claims] 1 ブレビバクテリウム ラクトフエルメンタム
(Brevibacterium lactofermentum)又はブレビ
バクテリウム フラバム(Brevibacterium
flavum)に属し、酢酸要求性を有する変異株。
1 Brevibacterium lactofermentum or Brevibacterium flavum
flavum) and has acetic acid auxotrophy.
JP17092679A 1979-12-27 1979-12-27 Variant Granted JPS5692784A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17092679A JPS5692784A (en) 1979-12-27 1979-12-27 Variant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17092679A JPS5692784A (en) 1979-12-27 1979-12-27 Variant

Publications (2)

Publication Number Publication Date
JPS5692784A JPS5692784A (en) 1981-07-27
JPS6234392B2 true JPS6234392B2 (en) 1987-07-27

Family

ID=15913913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17092679A Granted JPS5692784A (en) 1979-12-27 1979-12-27 Variant

Country Status (1)

Country Link
JP (1) JPS5692784A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4647391B2 (en) * 2005-05-20 2011-03-09 財団法人地球環境産業技術研究機構 Highly efficient production method of dicarboxylic acid by coryneform bacteria

Also Published As

Publication number Publication date
JPS5692784A (en) 1981-07-27

Similar Documents

Publication Publication Date Title
JP4734775B2 (en) Escherichia coli arginine-producing bacteria and method for producing L-arginine using the same
JP2817155B2 (en) Production method of L-arginine by fermentation method
JP2817157B2 (en) Production method of L-amino acid by fermentation method
JPH0430275B2 (en)
JP3016883B2 (en) Method for producing 5'-xanthylic acid by fermentation method
JP2810697B2 (en) Method for producing aromatic amino acids
JPH0362394B2 (en)
JPS6257315B2 (en)
JPH0362395B2 (en)
JP2876739B2 (en) Production method of L-lysine by fermentation method
JP3131311B2 (en) Production method of L-isoleucine by fermentation method
JP2578492B2 (en) Method for producing L-threonine by fermentation method
JPS6224073B2 (en)
JPS6224074B2 (en)
JP2578463B2 (en) Production method of L-lysine by fermentation method
JP2971089B2 (en) Method for producing L-threonine by fermentation
JPS6234392B2 (en)
JP2578474B2 (en) Method for producing L-glutamic acid
JPH057493A (en) Production of l-valine by fermentation
JPS6155958B2 (en)
JP2877414B2 (en) Method for producing L-threonine by fermentation
JPH0665314B2 (en) Fermentation method for producing L-valine
KR910008636B1 (en) Process for producing l - arginine
JPS6135840B2 (en)
CA1192157A (en) Fermentative preparation of l-leucine